Firmenbeschreibung
Dermapharm ist ein Hersteller von patentfreien Markenarzneimitteln für ausgewählte Märkte in Deutschland. Die 1991 gegründete Gesellschaft hat ihren Sitz in Grünwald bei München und ihren Hauptproduktionsstandort in Brehna bei Leipzig. Das integrierte Geschäftsmodell der Gesellschaft umfasst die hausinterne Entwicklung, eigene Produktion sowie den Vertrieb von Arzneimitteln und anderen Gesundheitsprodukten für ausgewählte Märkte durch einen pharmazeutisch geschulten Außendienst. Dermapharm verfügt über rund 1.300 Arzneimittelzulassungen für rund 400 pharmazeutische Wirkstoffe, die sich in einem breiten Produktsortiment widerspiegeln. Zu den Kernmärkten der Gesellschaft gehören derzeit neben Deutschland auch Österreich und die Schweiz. Die Gesellschaft plant, ihre internationale Präsenz weiter auszubauen. Das Geschäftsmodell von Dermapharm umfasst überdies ein Parallelimportgeschäft, das unter der Marke 'axicorp' betrieben wird. Im Segment Pflanzliche Extrakte verfügt Dermapharm über die spanische Euromed S.A. zudem über Zugang zum Wachstumsmarkt für pflanzliche Arzneimittel.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Themis Beteiligungs-AG (73.4%),Mawer Investment Management Ltd. (3%),Grandeur Peak Global Advisors, LLC (1.55%),Norges Bank Investment Management (1.31%),The Vanguard Group, Inc. (1.22%),Janus Henderson Group plc (0.99%),Amundi Asset Management SAS (0.73%) |
| sharesOutstanding: | 53840000.0000 |
| ceo: | Dr. Hans-Georg Feldmeier |
| board: | Christof Dreibholz, Dr. Andreas Eberhorn |
| supervisoryBoard: | Wilhelm Beier, Dr. Erwin Kern, Lothar Lanz |
| countryID: | 2 |
| faceValueCurrencyID: | 1 |
| faceValueCurrency: | EUR |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | Deutschland |
| countryName: | Deutschland |
Kontakt
| name: | Britta Hamberger |
| phone: | +49-89-64186-233 |
| fax: | +49-89-64186-165 |
| email: | ir@dermapharm.com |
| irWebSite: | https://ir.dermapharm.de/de/ |
Adresse
| street: | Lil-Dagover-Ring 7 |
| city: | D-82031 Grünwald |
| phone: | +49-89-64186-0 |
| fax: | +49-89-64186-130 |
| webSite: | ir.dermapharm.de/index.php |
Finanzen (kurz)
| year: | 2022 | cash: | 151.0000 |
| balanceSheetTotal: | 1412.8000 | liabilities: | 880.4000 |
| totalShareholdersEquity: | 531.6000 | sales: | 1024.8000 |
| investment: | 0.7000 | incomeBeforeTaxes: | 216.3000 |
| netIncome: | 132.6000 | employees: | 2563 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
| year: | 2023 | cash: | 158.7200 |
| balanceSheetTotal: | 2160.6700 | liabilities: | 1615.5100 |
| totalShareholdersEquity: | 539.2000 | sales: | 1135.3500 |
| investment: | 3.2200 | incomeBeforeTaxes: | 105.9900 |
| netIncome: | 58.1100 | employees: | 3497 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
| year: | 2024 | cash: | 121.3000 |
| balanceSheetTotal: | 2080.0100 | liabilities: | 1471.7100 |
| totalShareholdersEquity: | 604.4200 | sales: | 1180.7600 |
| investment: | 16.9400 | incomeBeforeTaxes: | 172.0000 |
| netIncome: | 113.7800 | currencyID: | 1 |
| units: | 1000000 | currency: | EUR |
Finanzen (kurz)
| year: | 2022 |
| cash: | 151.0000 |
| balanceSheetTotal: | 1412.8000 |
| liabilities: | 880.4000 |
| totalShareholdersEquity: | 531.6000 |
| sales: | 1024.8000 |
| investment: | 0.7000 |
| incomeBeforeTaxes: | 216.3000 |
| netIncome: | 132.6000 |
| employees: | 2563 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
| year: | 2023 |
| cash: | 158.7200 |
| balanceSheetTotal: | 2160.6700 |
| liabilities: | 1615.5100 |
| totalShareholdersEquity: | 539.2000 |
| sales: | 1135.3500 |
| investment: | 3.2200 |
| incomeBeforeTaxes: | 105.9900 |
| netIncome: | 58.1100 |
| employees: | 3497 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
| year: | 2024 |
| cash: | 121.3000 |
| balanceSheetTotal: | 2080.0100 |
| liabilities: | 1471.7100 |
| totalShareholdersEquity: | 604.4200 |
| sales: | 1180.7600 |
| investment: | 16.9400 |
| incomeBeforeTaxes: | 172.0000 |
| netIncome: | 113.7800 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
Finanzen (ausführlich)
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 2160.6700 | cash: | 158.7200 |
| currentAssets: | 630.4900 | fixedAssets: | 1530.1700 |
| liabilities: | 394.4800 | nonCurrentLiabilities: | 1221.1300 |
| totalLiabilitiesEquity: | 2160.6700 | provisions: | 256.9000 |
| totalShareholdersEquity: | 539.2000 | employees: | 3497 |
| property: | 330.7700 | intangibleAssets: | 544.8600 |
| longTermInvestments: | 23.6000 | inventories: | 320.7500 |
| accountsReceivable: | 90.9300 | accountsPayable: | 86.6400 |
| liabilitiesTotal: | 1615.5100 | longTermDebt: | 963.9500 |
| shortTermDebt: | 116.4300 | minorityInterests: | 5.8400 |
| sales: | 1135.3500 | depreciation: | 104.5800 |
| netIncome: | 58.1100 | operatingResult: | 182.8900 |
| incomeInterest: | -69.7400 | incomeTaxes: | 45.4600 |
| minorityInterestsProfit: | 1.8300 | revenuePerEmployee: | 324663.9977 |
| cashFlow: | 219.4200 | cashFlowInvesting: | -415.4300 |
| cashFlowFinancing: | 204.5300 | accountingStandard: | IFRS |
| equityRatio: | 24.9552 | debtEquityRatio: | 300.7177 |
| liquidityI: | 40.2352 | liquidityII: | 63.2858 |
| netMargin: | 5.1182 | cashFlowMargin: | 19.3262 |
| ebitMargin: | 16.1087 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 19.6569 | preTaxROA: | 4.9054 |
| roe: | 10.7771 | roa: | 2.6894 |
| netIncomeGrowth: | -56.1765 | revenuesGrowth: | 10.7875 |
| taxExpenseRate: | 42.8908 | equityTurnover: | 2.1056 |
| epsBasic: | 1.1600 | epsBasicGrowth: | -53.4137 |
| priceEarningsRatioCompany: | 36.5172 | priceCashFlowRatio: | 10.3940 |
| dividendYield: | 2.0774 | bookValuePerShare: | 10.0149 |
| marketCap: | 2280662400.0000 | earningsYield: | 2.7384 |
| pegRatio: | -0.6837 | cashFlowPerShare: | 4.0754 |
| netAssetsPerShare: | 10.1233 | priceBookValueRatio: | 4.2297 |
| dividendsPerShare: | 0.8800 | priceEarningsRatio: | 39.2473 |
| netEarningsPerShare: | 1.0793 | currency: | EUR |
| year: | 2024 | units: | 1000000 |
| balanceSheetTotal: | 2080.0100 | cash: | 121.3000 |
| currentAssets: | 593.4900 | fixedAssets: | 1486.5200 |
| liabilities: | 326.9100 | nonCurrentLiabilities: | 1144.8000 |
| totalLiabilitiesEquity: | 2080.0100 | provisions: | 143.0000 |
| totalShareholdersEquity: | 604.4200 | property: | 315.0200 |
| longTermInvestments: | 20.6600 | inventories: | 343.3800 |
| accountsReceivable: | 100.9000 | accountsPayable: | 94.7800 |
| liabilitiesTotal: | 1471.7100 | longTermDebt: | 889.6700 |
| shortTermDebt: | 89.9300 | minorityInterests: | 3.8700 |
| sales: | 1180.7600 | depreciation: | 90.4900 |
| netIncome: | 113.7800 | operatingResult: | 216.9300 |
| incomeInterest: | -46.4500 | incomeTaxes: | 60.2600 |
| minorityInterestsProfit: | -2.0500 | cashFlow: | 201.3700 |
| cashFlowInvesting: | -29.6100 | cashFlowFinancing: | -209.1600 |
| accountingStandard: | IFRS | equityRatio: | 29.0585 |
| debtEquityRatio: | 244.1332 | liquidityI: | 37.1050 |
| liquidityII: | 67.9698 | netMargin: | 9.6362 |
| cashFlowMargin: | 17.0543 | ebitMargin: | 18.3721 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 28.4570 |
| preTaxROA: | 8.2692 | roe: | 18.8247 |
| roa: | 5.4702 | netIncomeGrowth: | 95.8011 |
| revenuesGrowth: | 3.9996 | taxExpenseRate: | 35.0349 |
| equityTurnover: | 1.9535 | epsBasic: | 2.1100 |
| epsBasicGrowth: | 81.8966 | priceEarningsRatioCompany: | 18.4360 |
| priceCashFlowRatio: | 10.4006 | dividendYield: | 2.3136 |
| bookValuePerShare: | 11.2262 | marketCap: | 2094376000.0000 |
| earningsYield: | 5.4242 | pegRatio: | 0.2251 |
| cashFlowPerShare: | 3.7402 | netAssetsPerShare: | 11.2981 |
| priceBookValueRatio: | 3.4651 | dividendsPerShare: | 0.9000 |
| priceEarningsRatio: | 18.4072 | netEarningsPerShare: | 2.1133 |
| currency: | EUR |
| year: | 2025 | priceEarningsRatioCompany: | 17.2986 |
| priceCashFlowRatio: | 9.7590 | dividendYield: | 2.4658 |
| bookValuePerShare: | 11.2262 | marketCap: | 1965160000.0000 |
| earningsYield: | 5.7808 | pegRatio: | 0.2112 |
| cashFlowPerShare: | 3.7402 | netAssetsPerShare: | 11.2262 |
| priceBookValueRatio: | 3.2513 | priceEarningsRatio: | 17.2716 |
| netEarningsPerShare: | 2.1133 | currency: | EUR |
Finanzen (ausführlich)
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 2160.6700 |
| cash: | 158.7200 |
| currentAssets: | 630.4900 |
| fixedAssets: | 1530.1700 |
| liabilities: | 394.4800 |
| nonCurrentLiabilities: | 1221.1300 |
| totalLiabilitiesEquity: | 2160.6700 |
| provisions: | 256.9000 |
| totalShareholdersEquity: | 539.2000 |
| employees: | 3497 |
| property: | 330.7700 |
| intangibleAssets: | 544.8600 |
| longTermInvestments: | 23.6000 |
| inventories: | 320.7500 |
| accountsReceivable: | 90.9300 |
| accountsPayable: | 86.6400 |
| liabilitiesTotal: | 1615.5100 |
| longTermDebt: | 963.9500 |
| shortTermDebt: | 116.4300 |
| minorityInterests: | 5.8400 |
| sales: | 1135.3500 |
| depreciation: | 104.5800 |
| netIncome: | 58.1100 |
| operatingResult: | 182.8900 |
| incomeInterest: | -69.7400 |
| incomeTaxes: | 45.4600 |
| minorityInterestsProfit: | 1.8300 |
| revenuePerEmployee: | 324663.9977 |
| cashFlow: | 219.4200 |
| cashFlowInvesting: | -415.4300 |
| cashFlowFinancing: | 204.5300 |
| accountingStandard: | IFRS |
| equityRatio: | 24.9552 |
| debtEquityRatio: | 300.7177 |
| liquidityI: | 40.2352 |
| liquidityII: | 63.2858 |
| netMargin: | 5.1182 |
| cashFlowMargin: | 19.3262 |
| ebitMargin: | 16.1087 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 19.6569 |
| preTaxROA: | 4.9054 |
| roe: | 10.7771 |
| roa: | 2.6894 |
| netIncomeGrowth: | -56.1765 |
| revenuesGrowth: | 10.7875 |
| taxExpenseRate: | 42.8908 |
| equityTurnover: | 2.1056 |
| epsBasic: | 1.1600 |
| epsBasicGrowth: | -53.4137 |
| priceEarningsRatioCompany: | 36.5172 |
| priceCashFlowRatio: | 10.3940 |
| dividendYield: | 2.0774 |
| bookValuePerShare: | 10.0149 |
| marketCap: | 2280662400.0000 |
| earningsYield: | 2.7384 |
| pegRatio: | -0.6837 |
| cashFlowPerShare: | 4.0754 |
| netAssetsPerShare: | 10.1233 |
| priceBookValueRatio: | 4.2297 |
| dividendsPerShare: | 0.8800 |
| priceEarningsRatio: | 39.2473 |
| netEarningsPerShare: | 1.0793 |
| currency: | EUR |
| year: | 2024 |
| units: | 1000000 |
| balanceSheetTotal: | 2080.0100 |
| cash: | 121.3000 |
| currentAssets: | 593.4900 |
| fixedAssets: | 1486.5200 |
| liabilities: | 326.9100 |
| nonCurrentLiabilities: | 1144.8000 |
| totalLiabilitiesEquity: | 2080.0100 |
| provisions: | 143.0000 |
| totalShareholdersEquity: | 604.4200 |
| property: | 315.0200 |
| longTermInvestments: | 20.6600 |
| inventories: | 343.3800 |
| accountsReceivable: | 100.9000 |
| accountsPayable: | 94.7800 |
| liabilitiesTotal: | 1471.7100 |
| longTermDebt: | 889.6700 |
| shortTermDebt: | 89.9300 |
| minorityInterests: | 3.8700 |
| sales: | 1180.7600 |
| depreciation: | 90.4900 |
| netIncome: | 113.7800 |
| operatingResult: | 216.9300 |
| incomeInterest: | -46.4500 |
| incomeTaxes: | 60.2600 |
| minorityInterestsProfit: | -2.0500 |
| cashFlow: | 201.3700 |
| cashFlowInvesting: | -29.6100 |
| cashFlowFinancing: | -209.1600 |
| accountingStandard: | IFRS |
| equityRatio: | 29.0585 |
| debtEquityRatio: | 244.1332 |
| liquidityI: | 37.1050 |
| liquidityII: | 67.9698 |
| netMargin: | 9.6362 |
| cashFlowMargin: | 17.0543 |
| ebitMargin: | 18.3721 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 28.4570 |
| preTaxROA: | 8.2692 |
| roe: | 18.8247 |
| roa: | 5.4702 |
| netIncomeGrowth: | 95.8011 |
| revenuesGrowth: | 3.9996 |
| taxExpenseRate: | 35.0349 |
| equityTurnover: | 1.9535 |
| epsBasic: | 2.1100 |
| epsBasicGrowth: | 81.8966 |
| priceEarningsRatioCompany: | 18.4360 |
| priceCashFlowRatio: | 10.4006 |
| dividendYield: | 2.3136 |
| bookValuePerShare: | 11.2262 |
| marketCap: | 2094376000.0000 |
| earningsYield: | 5.4242 |
| pegRatio: | 0.2251 |
| cashFlowPerShare: | 3.7402 |
| netAssetsPerShare: | 11.2981 |
| priceBookValueRatio: | 3.4651 |
| dividendsPerShare: | 0.9000 |
| priceEarningsRatio: | 18.4072 |
| netEarningsPerShare: | 2.1133 |
| currency: | EUR |
| year: | 2025 |
| priceEarningsRatioCompany: | 17.2986 |
| priceCashFlowRatio: | 9.7590 |
| dividendYield: | 2.4658 |
| bookValuePerShare: | 11.2262 |
| marketCap: | 1965160000.0000 |
| earningsYield: | 5.7808 |
| pegRatio: | 0.2112 |
| cashFlowPerShare: | 3.7402 |
| netAssetsPerShare: | 11.2262 |
| priceBookValueRatio: | 3.2513 |
| priceEarningsRatio: | 17.2716 |
| netEarningsPerShare: | 2.1133 |
| currency: | EUR |
